NIH-funded research R03 grant

Making it easier to share laboratory test data for better research access

Official title: Simplifying the transformation of laboratory test data for integration into the ImmPort database

Funded at Cincinnati Childrens Hosp Med Ctr · NIH-11109648 · Data updated 2026-11-12

This study is working on a new tool to make it easier for researchers to share and use lab test data from clinical trials, which could help improve treatments and understanding of immune-related health issues for patients like you.

Quick facts

Grant typeR03 grant
Study typeNIH-funded research
Funding institutionCincinnati Childrens Hosp Med Ctr
NIH-funded
Lab location1 site (Cincinnati, United States)
Project startJune 6, 2024
Project endApril 30, 2026
Funding year2025
Award (this year)$80,250
NIH project number5R03AI185587-02
Project IDNIH-11109648 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for benefiting from this research include individuals with food allergies or other immunological conditions who are part of clinical trials.

Less likely to help

Patients who are not involved in clinical trials or do not have immunological conditions may not receive direct benefits from this research.

What this research studies

This research focuses on improving the way laboratory test data from clinical trials is shared and reused in biomedical research. It aims to develop an automated tool that transforms this data into a standardized format suitable for the ImmPort database, which is a public resource for immunological and clinical data. By simplifying the data submission process, the project seeks to enhance the accessibility and usability of clinical trial data for researchers, ultimately leading to better study designs and more robust findings. Patients may benefit indirectly as improved data sharing can lead to advancements in treatment and understanding of immunological conditions.

Why it matters

Potential benefit: If successful, this research could lead to more efficient use of clinical trial data, potentially accelerating advancements in treatments for patients with immunological conditions.

How similar studies have gone: Other research has shown success in improving data sharing and integration in biomedical fields, indicating that this approach has potential for positive outcomes.

Where this research is happening

  • Cincinnati Childrens Hosp Med Ctr
    Cincinnati, United States
    Active

Researchers

  • Principal investigator: Andorf, Sandra — Cincinnati Childrens Hosp Med Ctr
  • Study coordinator: Andorf, Sandra

Related research

Other NIH-funded projects on the same topics.

  • Accelerating Rheumatic Heart Disease Prevention in Uganda

    A program to find people with rheumatic heart disease in Ugandan communities and give them preventive care close to home.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11645314

  • Enhanced surveillance network to track childhood vaccines and viral infections in kids

    A nationwide pediatric surveillance network will closely watch how common viruses and vaccines affect children’s health, using standard protocols at hospital and ED sites.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11624109

  • Advancing CNS drug delivery through epigenetic tweaks

    A medical research project aims to help people with lysosomal storage disorders by improving how treatments reach the brain.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11617801

  • Spina Bifida Registry for Better Clinic Care

    A national registry project aims to improve care for people with spina bifida by collecting and sharing data from multidisciplinary clinics to guide evidence-based practices.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11616587

  • Hydroxyurea to help children with sickle cell anemia in Africa

    A pediatric study tests hydroxyurea treatment for young children with sickle cell anemia in several African countries to see if it can reduce illness and improve health.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11606512

  • Hydroxyurea for Children with Sickle Cell in Africa

    A pilot study tests hydroxyurea in young children with sickle cell disease across several African countries to see if it can reduce illness and hospital visits.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11606510

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.